Condition
Methanol Poisoning
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 3 (1)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06173817Phase 1WithdrawnPrimary
The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients
NCT06931587CompletedPrimary
Methanol Poisoning
NCT04877067Phase 3CompletedPrimary
Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation
NCT04064801CompletedPrimary
Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning
Showing all 4 trials